D L Carlson Investment Group Inc. increased its stake in shares of Masimo Corporation (NASDAQ:MASI) by 32.4% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 46,240 shares of the medical equipment provider’s stock after acquiring an additional 11,315 shares during the quarter. D L Carlson Investment Group Inc. owned about 0.09% of Masimo Corporation worth $4,216,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of MASI. JPMorgan Chase & Co. lifted its position in Masimo Corporation by 11.2% during the first quarter. JPMorgan Chase & Co. now owns 455,338 shares of the medical equipment provider’s stock valued at $42,466,000 after purchasing an additional 45,833 shares during the last quarter. Prudential Financial Inc. lifted its position in Masimo Corporation by 14.4% during the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock valued at $50,442,000 after purchasing an additional 69,810 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in Masimo Corporation by 27.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock valued at $99,872,000 after purchasing an additional 233,412 shares during the last quarter. Geode Capital Management LLC lifted its position in Masimo Corporation by 36.9% during the first quarter. Geode Capital Management LLC now owns 645,254 shares of the medical equipment provider’s stock valued at $60,175,000 after purchasing an additional 173,931 shares during the last quarter. Finally, Swiss National Bank lifted its position in Masimo Corporation by 0.9% during the first quarter. Swiss National Bank now owns 77,800 shares of the medical equipment provider’s stock valued at $7,256,000 after purchasing an additional 700 shares during the last quarter. Hedge funds and other institutional investors own 83.26% of the company’s stock.

Masimo Corporation (NASDAQ:MASI) traded up 1.39% during trading on Monday, reaching $85.55. 418,607 shares of the company’s stock traded hands. Masimo Corporation has a one year low of $53.78 and a one year high of $104.71. The company has a 50-day moving average price of $89.22 and a 200 day moving average price of $90.97. The firm has a market capitalization of $4.44 billion, a PE ratio of 14.02 and a beta of 0.84.

Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $192.90 million for the quarter, compared to analysts’ expectations of $189.03 million. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.57 EPS. On average, analysts anticipate that Masimo Corporation will post $2.80 earnings per share for the current fiscal year.

In other news, insider Rick Fishel sold 15,000 shares of the business’s stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $92.85, for a total transaction of $1,392,750.00. Following the transaction, the insider now owns 35,022 shares of the company’s stock, valued at approximately $3,251,792.70. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Sanford Fitch sold 14,000 shares of the business’s stock in a transaction dated Thursday, June 29th. The shares were sold at an average price of $92.06, for a total transaction of $1,288,840.00. Following the transaction, the director now directly owns 90,249 shares in the company, valued at approximately $8,308,322.94. The disclosure for this sale can be found here. In the last three months, insiders have sold 126,000 shares of company stock worth $11,732,930. Corporate insiders own 16.60% of the company’s stock.

TRADEMARK VIOLATION WARNING: This report was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.thecerbatgem.com/2017/09/04/d-l-carlson-investment-group-inc-raises-position-in-masimo-corporation-masi.html.

Several equities analysts have commented on MASI shares. Zacks Investment Research lowered shares of Masimo Corporation from a “strong-buy” rating to a “hold” rating in a research report on Thursday, May 11th. Roth Capital increased their price objective on shares of Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. Stifel Nicolaus started coverage on shares of Masimo Corporation in a research report on Monday, July 10th. They set a “buy” rating and a $105.00 price objective for the company. Wedbush reiterated an “outperform” rating and set a $112.00 price objective on shares of Masimo Corporation in a research report on Monday, May 22nd. Finally, BidaskClub upgraded shares of Masimo Corporation from a “hold” rating to a “buy” rating in a research report on Wednesday, July 12th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and four have given a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $95.00.

Masimo Corporation Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.